Patent law plays a vital role in encouraging innovation, scientific advancement, technological development, and economic growth by granting inventors exclusive rights over their inventions for a limited period. The Patents Act, 1970 governs patent protection in India and establishes a legal framework through which patent holders can prevent unauthorized use of patented inventions. A patent grants the patentee exclusive rights to make, use, sell, offer for sale, or import the patented product or process, thereby enabling inventors to commercially exploit their innovations and recover investments made in research and development.
However, patent rights are not restricted solely to patentees because the law also recognizes the interests of persons who derive rights through licences, including exclusive licensees and compulsory licence holders. These entities play an important role in the commercialization, distribution, and accessibility of patented technologies and are therefore granted certain legal protections and remedies under the Patents Act. In cases where patent rights are violated through unauthorized exploitation, infringement suits may be initiated before competent courts seeking various reliefs.
The nature and extent of reliefs available depend upon the legal status of the claimant, the terms of the licence, and the statutory framework governing patent enforcement. Understanding the reliefs available in an infringement suit and the rights of exclusive licensees and compulsory licence holders is crucial for patent owners, licensees, businesses, legal practitioners, and researchers involved in intellectual property law and commercial innovation. Under the Patents Act, 1970, patent infringement occurs when a person, without authorization from the patentee, makes, uses, sells, offers for sale, imports, or commercially exploits a patented invention during the term of the patent.
Section 48 of the Act grants exclusive rights to the patentee, while Sections 104 to 114 deal with suits concerning infringement and available remedies. Reliefs in patent infringement suits are intended to protect the exclusivity granted by patents, compensate for losses suffered due to infringement, prevent unjust enrichment by infringers, and deter future violations. The primary reliefs available in an infringement suit include injunctions, damages, accounts of profits, seizure and destruction of infringing goods, and costs of litigation.
These remedies are generally sought by patentees, but the law also extends certain rights to exclusive licensees and compulsory licence holders under specified circumstances. An exclusive licensee is a person or entity to whom the patentee grants exclusive rights to exploit the patented invention to the exclusion of all others, including the patentee himself in certain respects, depending upon the terms of the agreement. Section 2(1)(f) of the Patents Act defines an exclusive licence as a licence conferring on the licensee or persons authorized by him the exclusive right to work the patented invention in a specified territory or field.
Exclusive licences are commonly used in industries such as pharmaceuticals, biotechnology, engineering, information technology, and manufacturing, where commercialization of inventions often requires collaboration between patentees and business entities possessing production capabilities, distribution networks, or technical expertise. Since an exclusive licensee acquires significant commercial interests in the patented invention, the law recognizes the need to protect those interests against infringement.
Section 109 of the Patents Act specifically addresses the rights of exclusive licensees in infringement suits. It provides that an exclusive licensee shall have the same rights as the patentee to institute a suit for infringement committed after the date of the licence. This means that the exclusive licensee can independently initiate legal proceedings against infringers without necessarily waiting for the patentee to act. The rationale behind granting such rights is that infringement not only harms the patentee but also adversely affects the commercial interests, market share, profits, and contractual rights of the exclusive licensee.
However, Section 109 also requires that the patentee be made a party to the suit unless the patentee is already joined as a plaintiff. The purpose of this requirement is to ensure that all parties having an interest in the patent are represented before the court and that conflicting judgments are avoided. The patentee may join the suit as a co-plaintiff, but if he refuses to do so, he may be added as a defendant. One of the most important reliefs available to an exclusive licensee in an infringement suit is the grant of an injunction. Injunctions may be temporary, interim, interlocutory, or permanent. Temporary injunctions are generally sought at the beginning of litigation to restrain the infringer from continuing infringing activities during the pendency of the suit.
Courts grant interim injunctions after considering factors such as the existence of a prima facie case, balance of convenience, irreparable injury, and public interest. Permanent injunctions may be granted after the court determines that infringement has occurred. Since exclusive licensees often depend heavily on the exclusivity granted under the licence for their business operations, injunctions are critical in preserving their commercial rights and preventing market disruption. In addition to injunctions, exclusive licensees may seek damages for losses suffered due to infringement.
Damages are monetary compensation awarded to the aggrieved party for harm caused by the infringer’s conduct. Courts assess damages by considering factors such as lost profits, reduction in market share, price erosion, and harm to business reputation. An exclusive licensee who suffers direct commercial losses due to infringement may therefore claim damages proportionate to the injury suffered. Alternatively, the plaintiff may seek an account of profits, which requires the infringer to surrender profits earned through unauthorized use of the patented invention. The objective of this remedy is to prevent unjust enrichment and ensure that infringers do not benefit from wrongful conduct.
Another important remedy available in infringement suits is the seizure, forfeiture, or destruction of infringing goods and materials used for infringement. Section 108 empowers courts to order the delivery up or destruction of infringing products, packaging, machinery, or other articles predominantly used for creating infringing goods. This remedy helps eliminate infringing products from the market and prevents further unauthorized exploitation of the patented invention. Exclusive licensees may also seek litigation costs, including court fees, legal expenses, and expert witness fees, particularly in technically complex patent disputes.
The rights of compulsory licence holders differ significantly from those of patentees and exclusive licensees because compulsory licences arise through statutory intervention rather than voluntary contractual arrangements. A compulsory licence is granted under Chapter XVI of the Patents Act when certain statutory conditions are satisfied, such as failure to meet the reasonable requirements of the public, non-availability of the patented invention at a reasonably affordable price, or failure to work the patent in India. Section 84 empowers the Controller of Patents to grant compulsory licences after the expiration of three years from the date of grant of the patent.
Compulsory licensing is particularly significant in sectors involving public health, pharmaceuticals, agriculture, and essential technologies because it seeks to balance patent rights with public interest objectives. India’s first compulsory licence was granted in Bayer Corporation v. Natco Pharma Ltd., where Natco obtained a licence to manufacture and sell a generic version of Bayer’s patented anti-cancer drug Nexavar at a significantly reduced price. A compulsory licence holder acquires the legal right to use the patented invention subject to terms and conditions imposed by the Controller. However, unlike exclusive licensees, compulsory licence holders generally do not possess unrestricted proprietary rights over the patent. Their rights are limited by the scope and conditions of the compulsory licence.
Consequently, the ability of compulsory licence holders to institute infringement suits and claim reliefs is more restricted. The Patents Act does not expressly confer upon compulsory licence holders the same broad rights available to exclusive licensees under Section 109. Nevertheless, compulsory licence holders possess legally protected interests in the licensed invention and may seek legal remedies if their authorized rights are interfered with by third parties. For example, if another party engages in activities that unlawfully interfere with the compulsory licence holder’s lawful exploitation of the patent, legal action may be pursued depending upon the circumstances and the terms of the licence. Courts may recognize the commercial and statutory interests of compulsory licence holders while interpreting the scope of their rights.
However, because compulsory licences are granted primarily to advance public interest objectives rather than private exclusivity, the remedies available may be narrower compared to those available to patentees or exclusive licensees. The distinction between exclusive licensees and compulsory licence holders reflects the different legal foundations underlying their rights. Exclusive licences arise through private contractual arrangements in which the patentee voluntarily transfers significant exclusivity to another party. Compulsory licences, on the other hand, are imposed through statutory mechanisms intended to address market failures, public health concerns, or anti-competitive practices.
Consequently, exclusive licensees are generally treated more similarly to patentees in infringement litigation, while compulsory licence holders operate within a more limited statutory framework. Indian courts have played an important role in clarifying the rights and remedies available in patent infringement disputes. In cases such as F. Hoffmann-La Roche Ltd. v. Cipla Ltd., Bayer Corporation v. Union of India, and Novartis AG v. Union of India, courts examined the interplay between patent rights, public interest, pharmaceutical accessibility, and enforcement remedies.
These judgments highlight the judiciary’s attempt to balance protection of intellectual property with broader societal objectives. Patent litigation often involves complex technical evidence, expert testimony, claim interpretation, and questions concerning validity, infringement, licensing rights, and regulatory compliance. Consequently, courts exercise significant discretion while granting remedies and determining the appropriate balance between competing interests. Reliefs in infringement suits serve several important functions within the patent system. They protect the economic value of patents, encourage investment in innovation, preserve contractual expectations, deter unlawful conduct, and promote fair competition. At the same time, courts must ensure that remedies do not create unjust monopolies or adversely affect public welfare.
This balancing function is particularly important in sectors involving life-saving medicines, agricultural technologies, environmental innovations, and critical infrastructure. Exclusive licensees and compulsory licence holders contribute significantly to technology dissemination, manufacturing capacity, and market competition, making their legal protection an important component of the patent ecosystem. Businesses and innovators can minimize infringement risks by conducting patent due diligence, negotiating clear licensing agreements, monitoring market activities, maintaining proper documentation, and seeking legal advice regarding intellectual property compliance.
Exclusive license agreements should clearly define the scope of rights, territorial limitations, sublicensing rights, enforcement authority, dispute resolution mechanisms, and allocation of litigation expenses. Similarly, compulsory licence holders must ensure strict compliance with the terms imposed by the Controller to preserve the validity of their statutory rights. In conclusion, reliefs in patent infringement suits under the Patents Act, 1970 play a critical role in protecting intellectual property rights and promoting innovation while balancing public interest considerations.
Exclusive licensees possess substantial enforcement rights under Section 109 and may seek remedies such as injunctions, damages, accounts of profits, destruction of infringing goods, and litigation costs. Compulsory licence holders, although operating under a more limited statutory framework, also enjoy legal protection for their authorized use of patented inventions. The Indian patent system seeks to harmonize the interests of patentees, licensees, competitors, and society by providing effective remedies against infringement while ensuring accessibility, affordability, and technological progress. As industries become increasingly dependent on innovation and intellectual property, the importance of understanding infringement remedies and licensing rights will continue to grow within India’s evolving legal and commercial landscape.
Leave a Reply